DOTZ NANO LIMITED — Director's Dealing 2021

Dec 23, 2021

Appendix 3Y ������������������������������������

Rule 3.19A.2

Appendix 3Y

������������������������������������

Information or documents not available now must be given to ASX as soon as available. Information and documents given ����������������������������������������������������

Introduced 30/9/2001.

Name of entity	Dotz Nano Limited
ABN	71 125 264 575

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	DORON ELDAR
Date of last notice	6 August 2021

Part 1 - Change of �������������������������������������������

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the �����������������������������������������������������������������������������������

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	DORON ELDAR (Director and Beneficiary)
Date of change	20 December 2021
No. of securities held prior to change	277,778 Ordinary Shares 92,593 Unlisted Options � Exercisable at $0.09 and expiring on 11/12/2021 Unquoted ESOP Options: (a) Tranche 1: 440,000 unquoted options each with an exercise price of $0.07 per Share � Expire 31/12/22 (Tranche 1 Australian Options); (b) Tranche 2: 500,000 unquoted options each with an exercise price of $0.12 per Share � Expire 31/12/22 (Tranche 2 Australian Options); (c) Tranche 3: 500,000 unquoted options each with an exercise price of $0.12 per Share � Expire 31/12/22 (Tranche 3 Australian Options); and (d) Tranche 4: 500,000 unquoted options each with an exercise price of $0.20 per Share � Expire 31/12/23 (Tranche 4 Australian Options);
Class	DTZ - Fully Paid Ordinary Shares Exercise of Unlisted Options � Exercisable at $0.09 and expiring on 11/12/2021

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of ��������������������������

Number acquired	Exercise of 92,593 Unlisted Options � Exercisable at $0.09 and expiring on 11/12/2021
Number disposed	Nil
Value/Consideration includes brokerage/gst Note: If consideration is non-cash, provide details and estimated valuation	Exercise price of options was A$0.09 (Total Cost $8,333.37)
No. of securities held after change	370,371 Ordinary Shares (ASX: DTZ) Unquoted ESOP Options: (e) Tranche 1: 440,000 unquoted options each with an exercise price of $0.07 per Share � Expire 31/12/22 (Tranche 1 Australian Options); (f) Tranche 2: 500,000 unquoted options each with an exercise price of $0.12 per Share � Expire 31/12/22 (Tranche 2 Australian Options); (g) Tranche 3: 500,000 unquoted options each with an exercise price of $0.12 per Share � Expire 31/12/22 (Tranche 3 Australian Options); and (h) Tranche 4: 500,000 unquoted options each with an exercise price of $0.20 per Share � Expire 31/12/23 (Tranche 4 Australian Options);
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Exercise of Unquoted Options

Part 2 � �������������������������������������������

Note: ����������������������������������������������������������������������������������������������������������������������������� should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y ������������������������������������

Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 �[+] Closed period

art 3� +Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance wasrequired?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 3

Appendix 3Y ������������������������������������

Rule 3.19A.2

Appendix 3Y

������������������������������������

Information or documents not available now must be given to ASX as soon as available. Information and ��������������������������������������������������������������������

Introduced 30/09/01 Amended 01/01/11

Name of entity Dotz Nano Limited

ABN 71 125 264 575

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Ms Kerry Harpaz

Date of last notice 2 September 2021

Part 1 - �����������������������������������������������������

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the defin���������������������������������������������������� be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Refer Below
Date of change	20 December 2021

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Error! Unknown document property name.

Appendix 3Y ������������������������������������

No. of securities held prior to change Shares held by Marzameno Ltd a Cyprus based company with the ultimate beneficiary being my husband, Mr Natanel Harpaz � Indirect holding by BNP PARIBAS NOMINEES PTY LTD SIX SIS LTD for Marzameno Ltd a Cyprus based company with the ultimate beneficiary being my husband, Mr Natanel Harpaz � Shares held by Mr Natanel Harpaz my husband � Shares held by KNH INVESTMENTS (AUST) PTY LTD � Options held by Marzameno Ltd a Cyprus based company with the ultimate beneficiary being my husband, Mr Natanel Harpaz � Options held by KNH Investments (AUST) PTY Ltd	8,832,678 Ordinary Shares 2,500,000 Ordinary Shares 6,738,675 Ordinary Shares 100 Ordinary Shares 10,000,000 UNL Opt @ $0.09 exp 11/12/2021 2,307,408 UNL Opt @ $0.09 exp 11/12/2021
Class	DTZ � Ordinary Shares UNL Opt @ $0.09 exp 11/12/2021
Number acquired	Exercise of: (a) 10,000,000 UNL Opt @ $0.09 exp 11/12/2021 (b) 2,307,408 UNL Opt @ $0.09 exp 11/12/2021
Number disposed	Off-Market Trade: (a) 850,000 Ord Shares (ASX: DTZ) (b) 2,000,000 Ord Shares (ASX: DTZ)
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Exercise of: (a) 10,000,000 UNL Opt @ $0.09 exp 11/12/2021 � Total - $900,000.00 (b) 2,307,408 UNL Opt @ $0.09 exp 11/12/2021 � Total - $207,666.72 Off-Market Trade: (a) 850,000 Ord Shares (ASX: DTZ) � Total Consideration $297,500.00 (b) 2,000,000 Ord Shares (ASX: DTZ) � Total consideration - $600,000.00

• See chapter 19 for defined terms.

Appendix 3Y Page 2 Error! Unknown document property name.

01/01/2011

Appendix 3Y ������������������������������������

No. of securities held after change Shares held by Marzameno Ltd a Cyprus based company with the ultimate beneficiary being my husband, Mr Natanel Harpaz � Indirect holding by BNP PARIBAS NOMINEES PTY LTD SIX SIS LTD for Marzameno Ltd a Cyprus based company with the ultimate beneficiary being my husband, Mr Natanel Harpaz � Shares held by Mr Natanel Harpaz my husband � Shares held by KNH INVESTMENTS (AUST) PTY LTD � Shares held by KNH Investments (AUST) PTY Ltd	18,832,678 Ordinary Shares 2,500,000 Ordinary Shares 3,888,675 Ordinary Shares 100 Ordinary Shares 2,307,408 Ordinary Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Exercise of Options and Off-Market Trade

Part 2 � �������������������������������������������

Note: ����������������������������������������������������������������������������������������������������������������������������� should be disclosed in this part.

Detail of contract Loan Agreement

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3 Error! Unknown document property name.

Appendix 3Y ������������������������������������

Nature of interest	Pursuant to the Loan Agreement between Dotz Nano Limited (Company) and Marzameno Ltd (Marzameno), the Company agreed to provide the loan amount of up to A$300,000 (excluding interest) to Marzameno for the purpose of funding the payment of the exercise of up to 1/3 of 10,000,000 Options (each with an exercise price of $0.09 and exercisable on or before 11 December 2021) held by Marzameno. The loan is unsecured, accrues interest at 6% per annum, and must be repaid in full on 31 March 2022. Pursuant to the terms of the Loan Agreement, until all monies owing under the Loan Agreement are repaid in full, Marzameno must not dispose of any of 10,000,000 Ordinary Shares (issued pursuant to the exercise of 10,000,000 Options held by Marzameno) subject to certain exceptions (such as the Company providing consent).
Name of registered holder (if issued securities)	N/A
Date of change	10 December 2021
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	Marzameno was provided with the A$300,000 loan amount, which was used to fund the exercise of 1/3 of 10,000,000 Options held by Marzameno. On 20 December 2021, the Company issued 10,000,000 Ordinary Shares to Marzameno in respect to the exercise of the Options.
Interest after change	N/A

Part 3 �[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required?

• See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011

Error! Unknown document property name.

Appendix 3Y ������������������������������������

If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 5 Error! Unknown document property name.